Eve Health Group LimitedASX: EVE

EVE Raises $0.9m to Advance Drug Reformulation Strategy

· Issued by Eve Health Group Limited

Eve Health Group Limited has released a press release.

View Attachment

Earlier from Eve Health

All Eve Health news releases